RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.150
+0.140 (13.86%)
At close: Jan 8, 2026, 4:00 PM EST
1.170
+0.020 (1.74%)
After-hours: Jan 8, 2026, 4:40 PM EST
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $42.15 million as of January 8, 2026. Its market cap has increased by 52.70% in one year.
Market Cap
42.15M
Enterprise Value
29.04M
1-Year Change
52.70%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $42.15M, a decrease of -38.60%. That is a compound annual growth rate of -10.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 37.02M | 20.22% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |